Literature DB >> 19358844

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.

P Hemachandra Reddy1.   

Abstract

Mitochondria are the major source of energy for the normal functioning of brain cells. Increasing evidence suggests that the amyloid precursor protein (APP) and amyloid beta (Abeta) accumulate in mitochondrial membranes, cause mitochondrial structural and functional damage, and prevent neurons from functioning normally. Oligomeric Abeta is reported to induce intracellular Ca(2+) levels and to promote the excess accumulation of intracellular Ca(2+) into mitochondria, to induce the mitochondrial permeability transition pore to open, and to damage mitochondrial structure. Based on recent gene expression studies of APP transgenic mice and AD postmortem brains, and APP/Abeta and mitochondrial structural studies, we propose that the overexpression of APP and the increased production of Abeta may cause structural changes of mitochondria, including an increase in the production of defective mitochondria, a decrease in mitochondrial trafficking, and the alteration of mitochondrial dynamics in neurons affected by AD. This article discusses some critical issues of APP/Abeta associated with mitochondria, mitochondrial structural and functional damage, and abnormal intracellular calcium regulation in neurons from AD patients. This article also discusses the link between Abeta and impaired mitochondrial dynamics in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358844      PMCID: PMC2710427          DOI: 10.1016/j.expneurol.2009.03.042

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  74 in total

Review 1.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

Review 2.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12.

Authors:  Sic L Chan; Carsten Culmsee; Norman Haughey; Wolfram Klapper; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2002-10       Impact factor: 5.996

4.  High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain.

Authors:  Michael T Lin; David K Simon; Colette H Ahn; Lauren M Kim; M Flint Beal
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

5.  Mitochondrial abnormalities in Alzheimer's disease.

Authors:  K Hirai; G Aliev; A Nunomura; H Fujioka; R L Russell; C S Atwood; A B Johnson; Y Kress; H V Vinters; M Tabaton; S Shimohama; A D Cash; S L Siedlak; P L Harris; P K Jones; R B Petersen; G Perry; M A Smith
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

Authors:  I Maurer; S Zierz; H J Möller
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

7.  Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons.

Authors:  S L Chan; M Mayne; C P Holden; J D Geiger; M P Mattson
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

Review 8.  Dysregulation of calcium in Alzheimer's disease.

Authors:  Maria Brzyska; Danek Elbaum
Journal:  Acta Neurobiol Exp (Wars)       Date:  2003       Impact factor: 1.579

9.  Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation.

Authors:  Hsueh-Meei Huang; Hui Zhang; Hui Xu; Gary E Gibson
Journal:  Biochim Biophys Acta       Date:  2003-01-20

10.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.

Authors:  Hindupur K Anandatheerthavarada; Gopa Biswas; Marie-Anne Robin; Narayan G Avadhani
Journal:  J Cell Biol       Date:  2003-04-14       Impact factor: 10.539

View more
  109 in total

1.  Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.

Authors:  Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

2.  Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neurobiol Dis       Date:  2011-09-13       Impact factor: 5.996

3.  Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.

Authors:  Judit Oláh; Orsolya Vincze; Dezsõ Virók; Dóra Simon; Zsolt Bozsó; Natália Tõkési; István Horváth; Emma Hlavanda; János Kovács; Anna Magyar; Mária Szũcs; Ferenc Orosz; Botond Penke; Judit Ovádi
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

Review 4.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

5.  Betanodavirus B2 causes ATP depletion-induced cell death via mitochondrial targeting and complex II inhibition in vitro and in vivo.

Authors:  Yu-Chin Su; Jiann-Ruey Hong
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

6.  Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease.

Authors:  Maria Manczak; Ramesh Kandimalla; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

7.  Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state.

Authors:  Roberta Leonardi; Jerold E Rehg; Charles O Rock; Suzanne Jackowski
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.

Authors:  Davide Tampellini; Gunnar K Gouras
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

9.  Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.

Authors:  Antonella Bobba; Vito A Petragallo; Ersilia Marra; Anna Atlante
Journal:  Int J Alzheimers Dis       Date:  2010-09-02

10.  Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease.

Authors:  Kanae Iijima-Ando; Stephen A Hearn; Christopher Shenton; Anthony Gatt; Lijuan Zhao; Koichi Iijima
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.